Value-based payment models and management of newly diagnosed prostate cancer.

Avinash MagantySamuel R KaufmanMary K OerlineKassem S FarajMegan E V CaramVahakn B ShahinianBrent K Hollenbeck

Published in: Cancer medicine (2023)

How urologists participate in value-based payment models is not associated with treatment, potential overtreatment, and prostate cancer spending in men with newly diagnosed disease.

Keyphrases

newly diagnosed
prostate cancer
radical prostatectomy
health insurance
affordable care act
healthcare
human health
climate change
replacement therapy